TGFB1 and type 2 diabetes mellitus: To achieve these aims, we first utilized an in vivo T2DM rodent model of impaired bone repair (11, 12) to ascertain how hyperglycemic conditions influence TGF-β1 levels in young and aged tissues during implant osseointegration.